ArticlePreventive medicine reports2026
From aid dependence to domestic ownership: Risks, challenges, and policy pathways for sustaining immunisation gains in lower-income countries.
Article in Preventive medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Lower-income countries are increasingly expected to finance immunisation programmes as global health financing shifts from donor support to domestic ownership, in line with Immunization Agenda 2030 (IA2030). While rising domestic investment signals progress, concerns remain regarding whether countries have sufficient fiscal space and institutional capacity to sustain immunization gains independently. Methods: This commentary synthesizes published evidence from Gavi-supported and transitioning lower-income countries using literature available through April 2026 to evaluate financial, economic, and health system factors influencing the sustainability of immunization programmes. Results: Three interlocking risks are identified: limited fiscal space, rising vaccine and delivery costs, and macroeconomic instability linked to overlapping aid transitions. Persistent institutional weaknesses in procurement, budgeting, regulatory systems, and supply chain management further threaten sustainability. Evidence from past transitions shows mixed outcomes, with success associated with early financial planning, strong prioritisation of immunisation, and integration into national health systems. Conclusions: Although increased domestic investment is essential for country ownership, many lower-income countries are not yet fully prepared to sustain immunisation gains independently. A phased, risk-sensitive transition combining strengthened domestic financing with continued targeted global support is necessary to prevent reversals in coverage and equity.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.